TAYD · Taylor Devices Inc. Common Stock
View on chartInsiders & Stakes
| John Burgess | ▲ Buy | Option Exercise | 48,426 Shares held | 10/2/2026 | View profile |
| MCDONOUGH MARK V CHIEF FINANCIAL OFFICER | ▲ Buy | Option Exercise | 12,000 Shares held | 8/5/2022 | View profile |
| Alan Raymond Klembczyk President | ▲ Buy | Option Exercise | 10,123 Shares held | 9/18/2024 | View profile |
| Timothy John Sopko CHIEF EXECUTIVE OFFICER | ▲ Buy | Open Market | 10,000 Shares held | 4/23/2025 | View profile |
| Robert Michael Carey Director | ▼ Sell | Open Market | 7,721 Shares held | 4/28/2026 | View profile |
| Fritz Eric Armenat | ▼ Sell | Open Market | 0 Shares held | 1/23/2026 | View profile |
| Ira Sochet | ▼ Sell | Open Market | 0 Shares held | 1/10/2024 | View profile |
Transaction History
| John Burgess | ▲ Buy | Option Exercise | 5,000 | $69K | 10/2/2026 |
| Robert Michael Carey | ▼ Sell | Open Market | 3,445 | $197K | 4/28/2026 |
| Robert Michael Carey | ▼ Sell | Open Market | 1,555 | $86K | 4/28/2026 |
| John Burgess | ▲ Buy | Option Exercise | 5,000 | $82K | 4/13/2026 |
| John Burgess | ▼ Sell | Tax Withholding | 1,574 | $82K | 4/13/2026 |
| Fritz Eric Armenat | ▼ Sell | Open Market | 528 | $38K | 1/23/2026 |
| Fritz Eric Armenat | ▼ Sell | Open Market | 300 | $21K | 1/23/2026 |
| Fritz Eric Armenat | ▼ Sell | Open Market | 700 | $51K | 1/23/2026 |
| Fritz Eric Armenat | ▼ Sell | Open Market | 2,800 | $201K | 1/22/2026 |
| Fritz Eric Armenat | ▲ Buy | Option Exercise | 5,000 | $49K | 1/21/2026 |
| Fritz Eric Armenat | ▼ Sell | Tax Withholding | 672 | $49K | 1/21/2026 |
| Fritz Eric Armenat | ▼ Sell | Open Market | 3,820 | $280K | 1/14/2026 |
| Fritz Eric Armenat | ▼ Sell | Open Market | 300 | $22K | 1/14/2026 |
| Fritz Eric Armenat | ▲ Buy | Option Exercise | 5,000 | $60K | 1/9/2026 |
| Fritz Eric Armenat | ▼ Sell | Tax Withholding | 880 | $60K | 1/9/2026 |
| Timothy John Sopko | ▲ Buy | Open Market | 699 | $21K | 4/23/2025 |
| Timothy John Sopko | ▲ Buy | Open Market | 11 | $330 | 4/23/2025 |
| Timothy John Sopko | ▲ Buy | Open Market | 290 | $9K | 4/23/2025 |
| John Burgess | ▲ Buy | Option Exercise | 5,000 | $61K | 4/14/2025 |
| Timothy John Sopko | ▲ Buy | Open Market | 1,000 | $33K | 1/13/2025 |
| Robert Michael Carey | ▲ Buy | Option Exercise | 5,000 | $60K | 10/28/2024 |
| Robert Michael Carey | ▲ Buy | Option Exercise | 5,000 | $48K | 10/28/2024 |
| Robert Michael Carey | ▼ Sell | Tax Withholding | 2,279 | $107K | 10/28/2024 |
| Alan Raymond Klembczyk | ▲ Buy | Option Exercise | 3,000 | $38K | 9/18/2024 |
| Alan Raymond Klembczyk | ▲ Buy | Option Exercise | 5,000 | $48K | 9/18/2024 |
| John Burgess | ▲ Buy | Option Exercise | 5,000 | $45K | 4/8/2024 |
| Ira Sochet | ▼ Sell | Open Market | 459,015 | $9.1M | 1/10/2024 |
| John Burgess | ▲ Buy | Option Exercise | 5,000 | $39K | 3/16/2023 |
| Timothy John Sopko | ▲ Buy | Open Market | 1,000 | $14K | 1/19/2023 |
| Timothy John Sopko | ▲ Buy | Open Market | 1,000 | $11K | 10/20/2022 |
| Robert Michael Carey | ▲ Buy | Open Market | 2,500 | $27K | 10/3/2022 |
| MCDONOUGH MARK V | ▲ Buy | Option Exercise | 4,000 | $32K | 8/5/2022 |
| Timothy John Sopko | ▲ Buy | Open Market | 1,000 | $10K | 4/1/2022 |
| Timothy John Sopko | ▲ Buy | Open Market | 1,000 | $10K | 1/21/2022 |
| Timothy John Sopko | ▲ Buy | Open Market | 1,000 | $11K | 10/1/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Taylor Devices Reports Q1 Earnings and Revenue Misses
Taylor Devices posted Q1 earnings of $0.14 per share, far below the $0.82 estimate, and sales of $7.3 million versus the $13.1 million forecast. The results fall short of analyst expectations and may weigh on the stock. The company has recently touched its 200‑day moving average and its RSI is below 30, indicating a potential oversold condition.
Taylor Devices Reports Q1 Earnings and Revenue Misses. Taylor Devices posted Q1 earnings of $0.14 per share, far below the $0.82 estimate, and sales of $7.3 million versus the $13.1 million forecast. The results fall short of analyst expectations and may weigh on the stock. The company has recently touched its 200‑day moving average and its RSI is below 30, indicating a potential oversold condition.